VX penetration following percutaneous poisoning: A dermal microdialysis study in the guinea pig

Toxicology Mechanisms and Methods

Volumn 18, Issue 4, 2008, Pages 313-321

  Wetherell, Janet R ^a   Armstrong, Stuart J ^a   Read, Robert W ^b   Clough, Geraldine F ^c  

^a Biomedical Sciences Department   (United Kingdom)

^b Detection Department   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Anticholinesterase; Dermis; Guinea Pig; Microdialysis; Nerve Agent; Organophosphate; Penetration; Percutaneous; Persistence; VX

Indexed keywords

ORGANOPHOSPHORUS COMPOUND; RINGER SOLUTION;

ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; CONCENTRATION RESPONSE; DERMIS; DIALYSATE; GUINEA PIG; INTOXICATION; LIQUID CHROMATOGRAPHY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

CAVIA;

EID: 45949096348     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701884944     Document Type: Article

References (21)

1. Benschop, H. P., and Dejong, L. P. 1991. Toxicokinetics of soman - species variation and stereospecificity in elimination pathways. Neurosci. Biobehav. Rev. 15(1):73-77.
2. Berry, W. K., Davies, D. R., and Gordon, J. J. 1971. Protection of animals against soman (1,2,2-trimethylpropyl methylphosphonofluoridate) by pretreatment with some other organophosphorus compounds, followed by oxime and atropine. Biochem. Pharmacol. 20:125-134.
3. Bonierbale, E., Debordes, L., and Coppet, L. 1997. Application of capillary gas chromatography to the study of hydrolysis of the nerve agent VX in rat plasma. J. Chromatography B 688(2):255-264.
4. Boutsiouki, P., and Clough, G. F. 2004. Modulation of microvascular function following low-dose exposure to the organophosphorus compound malathion in human skin in vivo. J. Appl. Physiol. 97:1091-1097.
5. Boutsiouki, P., Thompson, J. P., and Clough, G. F. 2001. Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. Arch. Toxicol. 75(6):321-328.
6. Carver, M. P., Williams, P. L., and Riviere, J. E. 1989. The isolated perfused porcine skin flap. 3 Percutaneous-absorption pharmacokinetics of organophosphates, steroids, benzoic-acid, and caffeine. Toxicol. Appl. Pharmacol. 97(2):324-337.
7. Chang, S. K., Williams, P. L., Dauterman, W. C., and Riviere, J. E. 1994. Percutaneous-absorption, dermatopharmacokinetics and related bio-transformation studies of carbaryl, lindane, malathion, and parathion in isolated-perfused porcine skin. Toxicology 91(3):269-280.
8. Chilcott, R. P., Dalton, C. H., Hill, I., Davidson, C. M., Blohm, K. L., and Hamilton, M. G. 2003. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig. Hum. Exper. Toxicol. 22(5):255-261.
9. Clough, G. F. 2005. Microdialysis of large molecules. AAPS J. 7(3):E686-E692.
10. Dalton, C. H., Hattersley, I. J., Rutter, S. J., and Chilcott, R. P. 2006. Absorption of the nerve agent VX (O-ethyl-S-[2(diisopropylamino) ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. Toxicol. In Vitro 20(8):1532-1536.
11. Dirnhuber, P., French, M. C., Green, D. M., Leadbeater, L., and Stratton, J. A. 1978. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:295-299.
12. Duncan, E. J. S., Brown, A., Lundy, P., Sawyer, T. W., Hamilton, M., Hill, I., and Conley, J. D. 2002. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J. Appl. Toxicol. 22(3):141-148.
13. Gordon, J. J., Leadbeater, L., and Maidment, M. P. 1977. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 43:207-216.
14. Groth, L., and Benfeldt, E. 2006. In: Serup, J., Jemec, G. B. E., and Grove, G. L. (Eds.), The Handbook of Non Invasive Methods and Skin, CRC Taylor & Francis, New York.
15. Love, A. H., Vance, A. L., Reynolds, J. G., and Davisson, M. L. 2004. Investigating the affinities and persistence of VX nerve agent in environmental matrices. Chemosphere 57(10):1257-1264.
16. Maynard, R. L., and Beswick, F. W. 1992. Organophosphorus compounds as chemical warfare agents. In: Ballantyne, B., and Marrs, T. C. (Eds.), Clinical and Experimental Toxicology of Organophosphates and Carbamates, Butterworth Heinemann, London, pp. 373-385.
17. McCleverty, D., Lyons, R., and Henry, B. 2006. Microdialysis sampling and the clinical determination of topical dermal bioequivalence. Int. J. Pharmac. 308(1-2):1-7.
18. Reifenrath, W. G., Chellquist, E. M., Shipwash, E. A., Jederberg, W. W., and Krueger, G. G. 1984. Percutaneous penetration in the hairless dog, weanling pig and grafted athymic nude-mouse - evaluation of models for predicting skin penetration in man. Br. J. Dermatol. 111:123-135.
19. Van Der Schans, M. J., Lander, B. J., van der Wiel, H., Langenberg, J. P., and Benschop, H. P. 2003. Toxicokinetics of the nerve agent (+/)-VX in anesthetized and atropinised hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 191(1):48-62.
20. Wester, R. C., and Noonan, P. K. 1980. Relevance of animal models for percutaneous absorption. Int. J. Pharmac. 7:99-110.
21. Wetherell, J., Price, M., and Mumford, H. 2006. A novel approach for medical countermeasures to nerve agent poisoning in the guineapig. Neurotoxicology 27(4):485-491.